Prevalence of serotype specific antibody to equine encephalosis virus in Thoroughbred yearlings in South Africa (1999-2004).

Cohorts of yearlings were sampled over a period of 6 years in a retrospective serological survey to establish the annual prevalence of serotype specific antibody to equine encephalosis virus on Thoroughbred stud farms distributed within defined geographical regions of South Africa. Seasonal seroprevalence varied between 3.6% and 34.7%, revealing both single and multiple serotype infections in an individual yearling. During the course of this study serotypes 1 and 6 were most frequently and extensively identified while the remaining serotypes 2, 3, 4, 5 and 7 were all identified as sporadic and localized infections affecting only individual horses. This study of the seasonal prevalence of equine encephalosis virus has a corollary and serves as a useful model in the seasonal incidence of the serotypes of African horse sickness and bluetongue in regions where the respective diseases are endemic.

• Publication year

  2008

• Venue

  Onderstepoort Journal of Veterinary Research

• Publication date

  2008-08-31

• Fields of study

  Agricultural and Food Sciences, Medicine, Biology

• Identifiers
  DOI 10.4102/OJVR.V75I2.14PMID 18788209
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• West Nile virus infection of Thoroughbred horses in South Africa (2000-2001).

  2010cited by this paper
• Development and validation of enzyme linked immunosorbent assays for detection of equine encephalosis virus antibody and antigen

  2006cited by this paper
• Vectors: Culicoides spp.

  2004cited by this paper
• The classification of seven serotypes of equine encephalosis virus and the prevalence of homologous antibody in horses in South Africa.

  2002influential reference
• The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant.

  2002cited by this paper
• Circulation of African horsesickness virus in zebra (Equus burchelli) in the Kruger National Park, South Africa, as measured by the prevalence of type specific antibodies.

  1993cited by this paper
• Prevalence of antibodies against some equine viruses in zebra (Zebra burchelli) in the Kruger National Park, 1991-1992.

  1993cited by this paper
• Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep.

  1987cited by this paper
• The Reoviridae

  1983cited by this paper
• Protein synthesis in bluetongue virus-infected cells.

  1979cited by this paper
• The isolation and characterization of equine encephalosis and serologically related orbiviruses from horses.

  1978cited by this paper
• Studies on the in vitro and the in vivo transcription of the bluetongue virus genome.

  1972cited by this paper
• Cattle and Culicoides biting midges as possible overwintering hosts of bluetongue virus.

  1971cited by this paper
• The isolation and identification of further antigenic types of African horsesickness virus

  1962influential reference
• Immunological types of horsesickness virus and their significance in immunization

  1958cited by this paper

• Isolation, Genomic Characterization, and Pathogenicity of a Novel Duck Orbivirus Genetically Similar to Corriparta Virus in China

  2025cites this paper
• Clinical signs, clinical pathology and outcomes in horses infected naturally with equine encephalosis virus

  2025cites this paper
• Insights on Transmission, Spread, and Possible Endemization of Selected Arboviruses in Israel—Interim Results from Five-Year Surveillance

  2022cites this paper
• Equine Encephalosis Virus

  2022influential citation
• Epidemiology and Genomic Analysis of Equine Encephalosis Virus Detected in Horses with Clinical Signs in South Africa, 2010–2017

  2021cites this paper
• Seroprevalence of African horse sickness in selected donkey populations in Namibia

  2020cites this paper
• Quantitative RT-PCR assays for identification and typing of the Equine encephalosis virus

  2018cites this paper
• Analysis of the Association of Climate, Weather and Herd Immunity with the Spread of Equine Encephalosis Virus in Horses in Israel

  2017cites this paper
• The sero-prevalence and sero-incidence of African horse sickness and equine encephalosis in selected horse and donkey populations in Zimbabwe

  2017cites this paper
• Seroprevalence and risk factor analysis for exposure to equine encephalosis virus in Israel, Palestine and Jordan

  2017cites this paper
• Quantitative analysis of the probability of introducing equine encephalosis virus (EEV) into The Netherlands.

  2016cites this paper
• Equine encephalosis in Thoroughbred foals on a South African stud farm

  2015cites this paper
• Quantitative risk analysis of equine encephalosis introduction into the Netherlands

  2014influential citation
• [Reverse genetics systems for orbiviruses reveal the essential mechanisms in their replication].

  2014cites this paper
• Outbreak investigation and molecular characterization of African horse sickness virus circulating in selected areas of Ethiopia.

  2013cites this paper
• Development and evaluation of a real-time polymerase chain reaction assay for equine encephalosis virus

  2012influential citation
• African horse sickness virus dynamics and host responses in naturally infected horses

  2011cites this paper
• Equine encephalosis virus: evidence for circulation beyond southern Africa

  2011cites this paper
• [African horse sickness and equine encephalosis: must Switzerland get prepared].

  2010cites this paper
• Re-emergence of bluetongue, African horse sickness, and other Orbivirus diseases

  2010cites this paper
• Use of temperature sensitive microchip transponders to monitor body temperature and pyrexia in Thoroughbred foals

  2009cites this paper
• Peruvian horse sickness virus and Yunnan orbivirus, isolated from vertebrates and mosquitoes in Peru and Australia.

  2009cites this paper
• CHAPTER 26 – Miscellaneous Viral Diseases

  2007cites this paper